Department of Urology, Sun Yat-sen Memorial Hospital, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen University, 107W Yanjiang Road, Yuexiu District, Guangzhou, Guangdong, China.
Department of Urology, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, P. R. China.
Urol J. 2022 Nov 8;19(5):356-362. doi: 10.22037/uj.v19i.7195.
To explore the establishment of a scoring system that can provide a reference for clinical decision making regarding the endoscopic treatment of 1-2 cm lower pole stones (LPS).
The data of patients with renal calculi who were treated with percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) in three hospitals from January 2013 to December 2017 were analyzed retrospectively. Multivariable logistic analysis was performed to determine the statistically significant indicators and regression coefficients, which were used to construct the scoring system. The stone-free rate (SFR) and postoperative complication rates of PCNL and RIRS within the two fractional segments of the scoring system were compared to select the optimal procedures.
A total of 137 patients in the PCNL group and 152 patients in the RIRS group were included in this study. Five factors were found to be most predictive of endoscopic treatment choice: stone number, stone diameter, infundibulopelvic angle (IPA), infundibular length (IL), and infundibular width (IW), yielding a total score ranging from 0-5. In the 0-2 segments, the RIRS group had better outcomes than the PCNL group in terms of the postoperative complication rates (6.8% versus 18.0%, P = .026). In segments 3-5, the SFR of the PCNL group was significantly higher than that of the RIRS group (88.5% versus 70.6%, P = .017).
Our scoring system was based on the patient's preoperative imaging examination to measure the stone number, stone diameter, IPA, IL and IW. RIRS was recommended at 0-2 segments, and PCNL was recommended at 3-5 segments. This new scoring system is expected to provide guidance for urologists to make endoscopic treatment decisions for 1-2 cm LPS.
探索建立一种评分系统,为 1-2cm 下极结石(LPS)的内镜治疗临床决策提供参考。
回顾性分析 2013 年 1 月至 2017 年 12 月三所医院接受经皮肾镜碎石术(PCNL)或逆行肾内手术(RIRS)治疗肾结石患者的数据。采用多变量逻辑分析确定有统计学意义的指标和回归系数,用于构建评分系统。比较评分系统两个分段内 PCNL 和 RIRS 的无石率(SFR)和术后并发症发生率,选择最佳手术方式。
PCNL 组共纳入 137 例患者,RIRS 组共纳入 152 例患者。有 5 个因素被发现对内镜治疗选择最具预测性:结石数量、结石直径、肾盂漏斗角(IPA)、漏斗长度(IL)和漏斗宽度(IW),总分为 0-5 分。在 0-2 分段,RIRS 组术后并发症发生率低于 PCNL 组(6.8%比 18.0%,P=0.026)。在 3-5 分段,PCNL 组的 SFR 明显高于 RIRS 组(88.5%比 70.6%,P=0.017)。
本评分系统基于患者术前影像学检查,测量结石数量、结石直径、IPA、IL 和 IW。0-2 分段推荐 RIRS,3-5 分段推荐 PCNL。该新评分系统有望为泌尿科医生治疗 1-2cm LPS 提供内镜治疗决策指导。